Global Medicines Access

Strengthening Access to Essential Medicines in Emerging Markets

Analyze key barriers to access, including regulatory complexity, pricing structures, and supply chain limitations, and outline policy pathways to improve sustainable availability of essential medicines. 

📅 March 2026
✍ MAEM Policy Team

​

​

Supply Chains

Building Resilient Pharmaceutical Supply Chains

Discuss vulnerabilities in global pharmaceutical supply chains and explore strategies for strengthening manufacturing capacity, diversification, and logistics resilience across emerging markets.

📅 March 2026
✍ MAEM Policy Team

​

​

Biologics Access

Expanding Access to Biologic Therapies

Explore the challenges associated with biologics affordability, regulatory pathways, and biosimilar adoption in emerging health systems.

📅 March 2026
✍ MAEM Policy Team

​

​

Regulatory Systems

Regulatory Convergence and Medicines Access

Examine how regulatory cooperation and harmonization across regions can accelerate safe and efficient access to medicines.

📅 March 2026
✍ MAEM Policy Team

​

 

Future of Global Health Policy

Policy Pathways for Sustainable Medicines Access

Highlight emerging policy frameworks that support long-term access to medicines while encouraging pharmaceutical innovation.

📅 March 2026
✍ MAEM Policy Team

​

The views expressed in this insight reflect policy analysis developed by MAEM to support dialogue on medicines access.